ZA845601B - Antibiotic - Google Patents

Antibiotic

Info

Publication number
ZA845601B
ZA845601B ZA845601A ZA845601A ZA845601B ZA 845601 B ZA845601 B ZA 845601B ZA 845601 A ZA845601 A ZA 845601A ZA 845601 A ZA845601 A ZA 845601A ZA 845601 B ZA845601 B ZA 845601B
Authority
ZA
South Africa
Prior art keywords
formula
image
antibiotic
agent
compound
Prior art date
Application number
ZA845601A
Other languages
English (en)
Inventor
Chao-Min Liu
John Westley
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA845601B publication Critical patent/ZA845601B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/46Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin
    • C12P19/54Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin the cyclohexyl radical being bound directly to a nitrogen atom of two or more radicals, e.g. streptomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/445The saccharide radical is condensed with a heterocyclic radical, e.g. everninomycin, papulacandin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • C12R2001/55Streptomyces hygroscopicus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Fodder In General (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA845601A 1983-07-28 1984-07-19 Antibiotic ZA845601B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/518,233 US4510317A (en) 1983-07-28 1983-07-28 Antibiotic X-14934A

Publications (1)

Publication Number Publication Date
ZA845601B true ZA845601B (en) 1985-03-27

Family

ID=24063126

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA845601A ZA845601B (en) 1983-07-28 1984-07-19 Antibiotic

Country Status (21)

Country Link
US (1) US4510317A (xx)
EP (1) EP0133971B1 (xx)
JP (1) JPS6051198A (xx)
KR (1) KR910005629B1 (xx)
AT (1) ATE33390T1 (xx)
AU (1) AU575574B2 (xx)
CA (1) CA1253097A (xx)
DE (1) DE3470313D1 (xx)
DK (1) DK159452C (xx)
ES (1) ES534644A0 (xx)
FI (1) FI76836C (xx)
GR (1) GR82437B (xx)
HU (1) HU193017B (xx)
IE (1) IE57274B1 (xx)
IL (1) IL72517A (xx)
MC (1) MC1615A1 (xx)
NO (1) NO158881C (xx)
NZ (1) NZ209022A (xx)
PH (1) PH20120A (xx)
PT (1) PT78991B (xx)
ZA (1) ZA845601B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707493A (en) * 1983-02-15 1987-11-17 Pfizer Inc. 19-epi-dianemycin as an anticoccidial and antibacterial agent
US4591559A (en) * 1983-07-28 1986-05-27 Hoffmann-La Roche Inc. Antibiotic X-14934A and a method for its preparation
US4625041A (en) * 1984-02-17 1986-11-25 Pfizer Inc. Acidic polycyclic ether antibiotic
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
EP0209971B1 (en) * 1985-05-28 1991-03-06 Eli Lilly And Company Polyether antibiotic and process for its production
US5888788A (en) * 1994-05-18 1999-03-30 Union Nationale Des Groupements De Distillateurs D'alcool (Ungda) Use of ionophoretic polyether antibiotics for controlling bacterial growth in alcoholic fermentation
TW393413B (en) * 1996-01-19 2000-06-11 Shimano Kk Clipless bicycle pedal with large shoe-contacting area
US9605014B2 (en) * 2012-03-16 2017-03-28 University Of Georgia Research Foundation, Inc. Glycomimetics to inhibit pathogen-host interactions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953474A (en) * 1974-11-15 1976-04-27 Eli Lilly And Company Antibiotic A204I derivatives
GB2024806B (en) * 1978-03-16 1982-05-06 Taisho Pharmaceutical Co Ltd Onomycin derivatives
JPS5592387A (en) * 1978-12-29 1980-07-12 Taisho Pharmaceut Co Ltd Antibiotic substance tm-531
US4431665A (en) * 1979-08-13 1984-02-14 Syntex (U.S.A.) Inc. Acylated laidlomycin derivatives
FR2463144A1 (fr) * 1979-08-13 1981-02-20 Syntex Inc Nouveaux diesters de laidlomycine, leur procede de production, compositions a usage veterinaire les contenant et leur utilisation pour accroitre le rendement d'assimilation des aliments chez un ruminant
US4359583A (en) * 1980-09-16 1982-11-16 Taisho Pharmaceutical Co., Ltd. Antibiotics TM-531 B and TM-531 C
US4361649A (en) * 1981-07-20 1982-11-30 Pfizer Inc. Polycyclic ether antibiotic
GB2113671A (en) * 1982-01-19 1983-08-10 Pfizer Ltd Polycyclic ether antibiotics
GT198400008A (es) * 1983-02-15 1985-07-12 19-epi-dianemicina y procedimiento para el mismo
US4552843A (en) * 1984-02-17 1985-11-12 Pfizer Inc. Process for producing an acidic polycyclic ether antibiotic by cultivation of a novel strain of Streptomyces endus subspecies aureus

Also Published As

Publication number Publication date
NO158881B (no) 1988-08-01
DK159452B (da) 1990-10-15
PT78991B (en) 1986-10-23
IE57274B1 (en) 1992-07-01
ATE33390T1 (de) 1988-04-15
KR910005629B1 (ko) 1991-08-01
PT78991A (en) 1984-08-01
NZ209022A (en) 1987-08-31
CA1253097A (en) 1989-04-25
DK159452C (da) 1991-03-18
HUT36178A (en) 1985-08-28
MC1615A1 (fr) 1985-07-18
DK366084D0 (da) 1984-07-26
US4510317A (en) 1985-04-09
ES8600640A1 (es) 1985-10-16
AU3124684A (en) 1985-01-31
DK366084A (da) 1985-01-29
JPS6051198A (ja) 1985-03-22
ES534644A0 (es) 1985-10-16
AU575574B2 (en) 1988-08-04
FI76836B (fi) 1988-08-31
NO158881C (no) 1988-11-09
PH20120A (en) 1986-10-02
FI843009A0 (fi) 1984-07-27
EP0133971A1 (de) 1985-03-13
EP0133971B1 (de) 1988-04-06
NO843054L (no) 1985-01-29
GR82437B (xx) 1984-12-13
FI843009A (fi) 1985-01-29
KR850001291A (ko) 1985-03-18
IL72517A (en) 1988-03-31
IE841949L (en) 1985-01-28
FI76836C (fi) 1988-12-12
HU193017B (en) 1987-08-28
DE3470313D1 (en) 1988-05-11
IL72517A0 (en) 1984-11-30

Similar Documents

Publication Publication Date Title
ES477591A1 (es) Procedimiento para la obtencion de preparados farmaceuticos que contienen un derivado de cefem.
ES8605821A1 (es) Un procedimiento para la preparacion de aciltripeptidos in- munoestimulantes
ES470437A1 (es) Un procedimiento para la preparacion de nuevos esteres an- tibacterianos
ES2001794A6 (es) Un procedimiento para la preparacion de derivados de quinolina
ES476109A1 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
CA2053359A1 (en) Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
GR82437B (xx)
GR3036157T3 (en) 7-Acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation.
JPS5626814A (en) Antibacteria agent and its use
FR2355848A1 (fr) 7-(a-(2,3-dihydro-2-oxobenzimidazol-1-yl-carbonylamino) arylacetamido) cephalosporines
DE3461378D1 (en) Rifamycins derivatives and preparation and pharmaceutical compositions thereof
ES8800916A1 (es) Un procedimiento para preparar acidos beta-lactamo-hidroxamicos sulfatados en o
ES461688A1 (es) Un procedimiento para la preparacion de nuevos compuestos decefalosporina.
ES8602812A1 (es) Un procedimiento para obtener esteres de cefalosporina
HUT42492A (en) Process for producing cepheme-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents